SUCCESSFUL INVESTING: ; Eli Lilly's Stock Gets 'Buy' Rating
INS News - Lilly's Cialis drug for erectile dysfunction had worldwide sales of $750 million last year, though Pfizer is suing Lilly with The company is testing an anti-cancer pill that could shrink brain tumors and potentially other forms of cancer. A federal